Bordetella pertussis and outer membrane vesicles

References

• Nieves DJ, Heininger U . Bordetella pertussis. Microbiol Spectr. 2016;4(3). DOI:10.1128/microbiolspec.EI10-0008-2015
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29(3):449–486. DOI:10.1128/CMR.00083-15
   PubMed Web of Science ®Google Scholar
• Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol. 2019;59:72–78. Accessed11 08 2002.
   PubMed Web of Science ®Google Scholar
• Black S. Epidemiology of pertussis. Pediatr Infect Dis J. 1997;16:S85–S89. Accessed 10 08 2022.
   PubMed Web of Science ®Google Scholar
• WHO. Pertussis vaccines: WHO position paper, August 2015. Weekly Epidemiological Record. 2015 Accessed 28 06 2022;90(35):433–460.
   Google Scholar
• Dilli D, Bostanci İ, Dallar Y, et al. Recent findings on pertussis epidemiology in Turkey. Eur J Clin Microbiol Infect Dis. 2008;27(5):335–341. DOI:10.1007/s10096-007-0442-x
   PubMed Web of Science ®Google Scholar
• Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis. 2005;24(5):S10–S18.
   Google Scholar
• Yasui Y, Mitsui T, Nishimura T, et al. School-Age children and adolescents suspected of having been to be infected with pertussis in Japan. Vaccine. 2018;36(20):2910–2915. Accessed 11 08 2022.
   PubMed Web of Science ®Google Scholar
• Bento AI, Riolo MA, Choi YH, et al. Core pertussis transmission groups in England and Wales: a tale of two eras. Vaccine. 2018;36(9):1160–1166. DOI:10.1016/j.vaccine.2018.01.046
   PubMed Web of Science ®Google Scholar
• WHO [Internet] Pertussis. Available from: https://www.who.int/health-topics/pertussis#tab=tab1.
   Google Scholar
• ECDC [Internet]. Pertussis: annual epidemiological report for 2017, Stockholm. [cited 2019 Apr]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-pertussis.pdf.
   Google Scholar
• Decker MD, Edwards KM. Pertussis (Whooping cough). J Infect Dis. 2021;224(Supplement_4):S310–S320.
   PubMedGoogle Scholar
• . CDCMortality and morbidity weekly report. pertussis vaccination: use of acellular pertussis vaccines among infants and young children recommendations of the advisory committee on immunization practices (ACIP). Available from. 1997;46(RR–7):1–25. https://www.cdc.gov/mmwr/preview/mmwrhtml/00048610.htm
   Google Scholar
• Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185(10):1448–1453. DOI:10.1086/340280
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. Nejm. 2012;367(11):1012–1019. DOI:10.1056/NEJMoa1200850
   PubMed Web of Science ®Google Scholar
• Rumbo M, Hozbor, Hozbor D. Development of improved pertussis vaccine. Hum Vaccine Immunother. 2014;10(8):2450–2453.
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in nonhuman primate model. Proc Natl Acad Sci, USA. 2014;111(2):787–792.
   PubMed Web of Science ®Google Scholar
• Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. J Infect Dis. 2004;190(3):535–544. DOI:10.1086/422035
   PubMed Web of Science ®Google Scholar
• Breakwell L, Kelso P, Finley C, et al. Pertussis vaccine effectiveness in the setting of pertactin-deficient pertussis. Pediatrics. 2016;137(5):e20153973. DOI:10.1542/peds.2015-3973
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. Mbio. 2014;5(2):e01074. DOI:10.1128/mBio.01074-14
   PubMed Web of Science ®Google Scholar
• Quinlan T, Musser KA, Currenti SA, et al. Pertactin-Negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004–2013. Mol Cell Press. 2013;28(4):138–140. DOI:10.1016/j.mcp.2013.12.003
   PubMed Web of Science ®Google Scholar
• Bodilis H, Guiso N. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis. 2013;19(3):471–474.
   PubMed Web of Science ®Google Scholar
• Lam C, Octavia S, Ricaford L, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014;20(4):626–633. DOI:10.3201/eid2004.131478
   PubMed Web of Science ®Google Scholar
• Hiramatsu Y, Miyaji Y, Otsuka N, et al. Significant decrease in pertactin-deficient Bordetella pertussis isolates, Japan. Emerg Infect Dis. 2017;23(4):699–701. DOI:10.3201/eid2304.161575
   PubMed Web of Science ®Google Scholar
• Zomer A, Otsuka N, Hiramatsu Y, et al. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Microb Genom. 2018;4(5):e000180. DOI:10.1099/mgen.0.000180
   PubMed Web of Science ®Google Scholar
• Barkoff AM, Mertsola J, Pierard D, et al. Pertactin-Deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill. 2019;24(7):1700832. DOI:10.2807/1560-7917.ES.2019.24.7.1700832
   PubMedGoogle Scholar
• Tozzi AE, Celentano LP, Ciofi Degli Atti ML, et al. Diagnosis and management of pertussis. Cmaj. 2005;172(4):509–515. DOI:10.1503/cmaj.1040766
   PubMed Web of Science ®Google Scholar
• Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther. 2004;2(3):447–454. Accessed 10 04 2022.
   PubMedGoogle Scholar
• CDC [Internet]. Photos of pertussis. Available from: https://www.cdc.gov/pertussis/about/photos.html.
   Google Scholar
• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–382. Accessed 10 04 2022.
   PubMed Web of Science ®Google Scholar
• Australian Government, Department of Health [Internet]. Pertussis laboratory case definition (LCD). Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-phlncd-pertussis.htm.
   Google Scholar
• Wood N, Mclntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev. 2008;9(3):201–211. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Kandeil W, Atanasov P, Avramioti D, et al. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–455. DOI:10.1080/14760584.2019.1588727
   PubMed Web of Science ®Google Scholar
• Toubiana J, Azarnoush S, Bouchez V, et al. Bordetella parapertussis bacteremia: clinical expression and bacterial genomics. US: Oxford University Press; 2019. p. ofz122. Accessed 20 07 2022.
   Google Scholar
• Lauria AM, Zabbo CP. Pertussis. In: StatPearls. StatPearls Publishing; 2022 https://www.ncbi.nlm.nih.gov/books/NBK519008/. Acccessed 21 07 2022.
   Google Scholar
• Decker KB, James TD, Stibitz S, et al. The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology. 2012;158(Pt 7):1665–1676. DOI:10.1099/mic.0.058941-0
   PubMedGoogle Scholar
• Jones AM, Boucher PE, Williams CL, et al. Role of BvgA phosphorylation and DNA binding affinity in control of Bvg-mediated phenotypic phase transition in Bordetella pertussis. Mol Microbiol. 2005;58(3):700–713. DOI:10.1111/j.1365-2958.2005.04875.x
   PubMed Web of Science ®Google Scholar
• Cotter PA, Jones AM. Phosphorelay control of virulence gene expression in Bordetella. Trends Microbiol. 2003;11(8):367–373. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Cummings CA, Bootsma HJ, Relman DA, et al. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol. 2006;188(5):1775–1785. DOI:10.1128/JB.188.5.1775-1785.2006
   PubMed Web of Science ®Google Scholar
• Bone MA, Wilk AJ, Perault AI, et al. Bordetella PlrSR regulatory system controls BvgAS acitivity and virulence in the lower respiratory tract. Proc Natl Acad Sci, USA. 2017;114(8):E1519–E1527. DOI:10.1073/pnas.1609565114
   PubMed Web of Science ®Google Scholar
• Dupre E, Herrou J, Lensink MF, et al. Virulence regulation with Venus flytrap domains: structure and function of the periplasmic moiety of the sensor-kinase BvgS. PLoS Pathog. 2015;11(3):e1004700. DOI:10.1371/journal.ppat.1004700
   PubMed Web of Science ®Google Scholar
• Herrou J, Bompard C, Wintjens R, et al. Periplasmic domain of the sensor-kinase BvgS reveals a new paradigm for the Venus flytrap mechanisms. Proc Natl Acad Sci, USA. 2010;107(40):17351–17355. DOI:10.1073/pnas.1006267107
   PubMed Web of Science ®Google Scholar
• Melvin JA, Scheller EV, Miller JF, et al. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol. 2014;12(4):274–288. DOI:10.1038/nrmicro3235
   PubMed Web of Science ®Google Scholar
• Moon K, Bonocora RP, Kim DD, et al. The BvgAS regulon of Bordetella pertussis. Mbio. 2017;8(5):e01526. DOI:10.1128/mBio.01526-17
   PubMed Web of Science ®Google Scholar
• Veal-Carr WL, Stibitz S. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET. Mol Microbiol. 2005;55(3):788–798. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Stockbauer KE, Fuchslocher B, Miller JF, et al. Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol Microbiol. 2001;39(1):65–78. DOI:10.1046/j.1365-2958.2001.02191.x
   PubMed Web of Science ®Google Scholar
• Henderson IR, Nataro JP, Portnoy DA. Virulence functions of autotransporter proteins. Infect Immun. 2001;69(3):1231–1243.
   PubMed Web of Science ®Google Scholar
• Locht C Molecular aspects of Bordetella pertussis pathogenesis. Int Microbiol. 1999 2(3):137–144. Accessed 08 04 2022.
   PubMedGoogle Scholar
• Atakan-Ablay P, Özcengiz E. Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities. Microbiol Bul. 2007;41(11):11–20. Accessed 08 04 2022.
   PubMedGoogle Scholar
• Locht C, Antoine R. The history of pertussis toxin. Toxins (Basel). 2021;13(9):623. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Knapp O, Benz R. Membrane activity and channel formation of the adenylate cyclase toxin (CyaA) of Bordetella pertussis in lipid bilayer membranes. Toxins (Basel). 2020;12(3):169. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Brookes C, Freire-Martin I, Cavell B, et al. Bordetella pertussis isolates vary in their interactions with human complement components. Emerg Microbes & Infect. 2018;7(1):1–11. DOI:10.1038/s41426-018-0084-3
   PubMed Web of Science ®Google Scholar
• Guiso N. Bordetella pertussis and pertussis vaccines. Clin Infect Dis. 2009;49(10):1565–1569. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Hewlett EL, Burns DL, Cotter PA, et al. Pertussis pathogenesis—what we know and what we don’t know. J Infect Dis. 2014;209(7):982–985. DOI:10.1093/infdis/jit639
   PubMed Web of Science ®Google Scholar
• Guiso N, Meade BD, Wirsing von König CH. Pertussis: the first hundred years. Vaccine. 2020;38(5):1271–1276. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Ligon BL. Pertussis: an historical review of the research and of the development of whole-cell and acellular vaccines. Semin Pediatr Infect Dis. 1998;9(2):168–178.
   Google Scholar
• Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child. 1974;49(1):46–49. Accessed 11 08 2022.
   PubMed Web of Science ®Google Scholar
• Cherry JD. The 112-Year odyssey of pertussis and pertussis vaccines – Mistakes made and implications for the future. J Pediatric Infect Dis Soc. 2019;8(4):334–341. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Chitkara AJ, Ferrer MP, Forsyth K, et al. Pertussis vaccination in mixed markets: recommendations from the global pertussis initiative. Int J Infect Dis. 2020;96:482–488. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet. 1984;323(8369):122–126. Accessed 08 04 2022.
   Google Scholar
• Waters V, Halperin S. Bordetella pertussis. Mandell, Douglas and bennett’s principles and practice of infectious diseases. Philadelphia: Churchill Livingstone Elsevier; 2010. Accessed 08 04 2022.
   Google Scholar
• Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics. 1995;96(3):548–557. DOI:10.1542/peds.96.3.548
   PubMed Web of Science ®Google Scholar
• Diavatopoulos DA, Edwards KM. What is wrong with pertussis vaccine immunity? Why immunological memory to pertussis is failing. Cold Spring Harb Perspect Biol. 2017;9(12):a029553. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Brummelman J, Mieszko MW, Wanda GHH, et al. Roads to the development of improved pertussis vaccines paved by immunology. Pathog Dis. 2015;73(8):ftv067. DOI:10.1093/femspd/ftv067
   PubMed Web of Science ®Google Scholar
• Peppoloni S, Nencioni A, Tommaso D, et al. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun. 1991;59(10):3768–3773. DOI:10.1128/iai.59.10.3768-3773.1991
   PubMed Web of Science ®Google Scholar
• Mills KH, Ross PJ, Allen AC, et al. Do we need a new vaccine to control the re-emergence of pertussis? Trends Microbiol. 2014;22(2):49–52. DOI:10.1016/j.tim.2013.11.007
   PubMed Web of Science ®Google Scholar
• Fedele G, Stefanelli P, Spensieri F, et al. Bordetella pertussis -infected human monocyte-derived dendritic cells undergo maturation and induce th1 polarization and interleukin-23 expression. Infect Immun. 2005;73(3):1590–1597. DOI:10.1128/IAI.73.3.1590-1597.2005
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol. 2013;6(4):787–796.
   PubMed Web of Science ®Google Scholar
• Wilk MM, Misiak A, McManus RM, et al. Lung CD4 tissue-resident memory T cells mediate adaptive immunity induced by previous infection of mice with Bordetella pertussis. J Immunol. 2017;199(1):233–243. DOI:10.4049/jimmunol.1602051
   PubMed Web of Science ®Google Scholar
• Brummelman J, Helm K, Hamstra HJ, et al. Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation. Vaccine. 2015;33(12):1483–1491. DOI:10.1016/j.vaccine.2015.01.063
   PubMed Web of Science ®Google Scholar
• Raeven RH, van der Maas L, Tilstra W, et al. Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity. J Proteome Res. 2015;14(7):2929–2942. DOI:10.1021/acs.jproteome.5b00258
   PubMed Web of Science ®Google Scholar
• da Silva Antunes R, Babor M, Carpenter C, et al. Th1/th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters. J Clin Invest. 2018;128(9):3853–3865. DOI:10.1172/JCI121309
   PubMed Web of Science ®Google Scholar
• Dewan KK, Linz B, DeRocco SE, et al. Acellular pertussis vaccine components: today and tomorrow. Vaccines (Basel). 2020;8(2):217. DOI:10.3390/vaccines8020217
   PubMed Web of Science ®Google Scholar
• Sugai T, Mori M, Nakazawa M, et al. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Vaccine. 2005;23(46–47):5450–5456. DOI:10.1016/j.vaccine.2004.09.041
   PubMed Web of Science ®Google Scholar
• Misiak A, Leuzzi R, Allen AC, et al. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model. Vaccine. 2017;35(39):5256–5263. DOI:10.1016/j.vaccine.2017.08.009
   PubMed Web of Science ®Google Scholar
• Boehm DT, Wolf MA, Hall JM, et al. Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis. NPJ Vaccines. 2019;4(1):40. DOI:10.1038/s41541-019-0136-2
   PubMedGoogle Scholar
• Locht C. Will we have new pertussis vaccines? Vaccine. 2018;36(6):5460–5469. Accessed 20 07 2022.
   PubMedGoogle Scholar
• Vidakovics ML, Paba J, Lamberti CA, et al. Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res. 2007;6(7):2518–2528. DOI:10.1021/pr060681i
   PubMed Web of Science ®Google Scholar
• Tefon BE, Maass S, Ozcengiz E, et al. A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins. Vaccine. 2011;29(19):3583–3595. DOI:10.1016/j.vaccine.2011.02.086
   PubMed Web of Science ®Google Scholar
• Alvarez Hayes J, Erben E, Lamberti Y, et al. Bordetella pertussis iron regulated proteins as potential vaccine components. Vaccine. 2013;31(35):3543–3548. DOI:10.1016/j.vaccine.2013.05.072
   PubMed Web of Science ®Google Scholar
• De Gouw D, de Jonge MI, Hermans P, et al. Proteomics-Identified Bvg-activated autotransporters protect against Bordetella pertussis in a mouse model. PLoS One. 2014;9(8):e105011. DOI:10.1371/journal.pone.0105011
   PubMed Web of Science ®Google Scholar
• Yılmaz Ç, Apak A, Özcengiz E, et al. Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models. Microbiol Immunol. 2016;60(11):717–724. DOI:10.1111/1348-0421.12445
   PubMed Web of Science ®Google Scholar
• Marr N, Oliver DC, Laurent V, et al. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. Vaccine. 2008;26:4306–4311. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Boehm DT, Hall J, Wong TY, et al. Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a Bordetella pertussis challenge model in mice. Infect Immun. 2018;86(10):17–e00857. Accessed 20 07 2022.
   Web of Science ®Google Scholar
• Mielcarek N, Debrie AS, Raze D, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog. 2006;2(7):e65. DOI:10.1371/journal.ppat.0020065
   PubMed Web of Science ®Google Scholar
• Thorstensson R, Trollfors B, Al-Tawil N, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine – BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014;9(1):e83449. DOI:10.1371/journal.pone.0083449
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Gamaleya Research Institute of Epidemiology and Microbiology. Identifier: NCT04036526, a Phase 1/2 clinical trial of a GamLPV, a live intranasal Bordetella pertussis vaccine; 2019 July 29 [cited 2022 August 10]. Available from: https://clinicaltrials.gov/ct2/show/NCT04036526?cond=NCT04036526&draw=2&rank=1.
   Google Scholar
• Micoli F, MacLennan CA. Outer membrane vesicle vaccines. Semin Immunol. 2020;50:101433. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• O’Ryan M, Stoddard J, Toneatto D, et al. A multi-component meningococcal serogroup B vaccine (4cmenb): the clinical development program. Drugs. 2014;74(1):15–30. DOI:10.1007/s40265-013-0155-7
   PubMed Web of Science ®Google Scholar
• Deatherage BL, Cookson BT, Andrews-Polymenis HL. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun. 2012;80(6):1948–1957.
   PubMed Web of Science ®Google Scholar
• Dorward DW, Garon CF. DNA is packaged within membrane-derived vesicles of Gram-negative but not Gram-positive bacteria. Appl Environ Microbiol. 1990;56(6):1960–1962. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Ellen AF, Albers SV, Huibers W, et al. Proteomic analysis of secreted membrane vesicles of archaeal Sulfolobus species reveals the presence of endosome sorting complex components. Extremophiles. 2009;13(1):67–79. DOI:10.1007/s00792-008-0199-x
   PubMed Web of Science ®Google Scholar
• Prados-Rosales R, Baena A, Martinez LR, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Investig. 2011;121(4):1471–1483. DOI:10.1172/JCI44261
   PubMed Web of Science ®Google Scholar
• Rivera J, Cordero RJ, Nakouzi AS, et al. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Pnas. 2010;107(44):19002–19007. DOI:10.1073/pnas.1008843107
   PubMed Web of Science ®Google Scholar
• McBroom AJ, Johnson AP, Vemulapalli S, et al. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol. 2006;188(15):5385–5392. DOI:10.1128/JB.00498-06
   PubMed Web of Science ®Google Scholar
• Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74(1):81–94. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Bishop DG, Work E. An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions. Biochemic J. 1965;96(2):567–576.
   PubMed Web of Science ®Google Scholar
• Knox KW, Vesk M, Work E. Relation between excreted lipopolysaccharide complexes and surface structures of a lysine-limited culture of Escherichia coli. J Bacteriol. 1966;92(4):1206–1217.
   PubMed Web of Science ®Google Scholar
• Chatterjee SN, Das J. Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. Microbiol. 1967;49(1):1–11. Accessed 08 04 2022.
   Google Scholar
• Schwechheimer C, Kuehn MJ. Outer-Membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol. 2015;13(10):605–619. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17(1):13–24. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• DeVoe IW, Gilchrist JE. Pili on meningococci from primary cultures of nasopharyngeal carriers and cerebrospinal fluid of patients with acute disease. J Exp Med. 1975;141(2):297–305. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Schooling SR, Beveridge TJ. Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol. 2006;188(16):5945–5957. Accessed 06 04 2022.
   PubMed Web of Science ®Google Scholar
• Palsdottir H, Remis JP, Schaudinn C, et al. Three-Dimensional macromolecular organization of cryofixed Myxococcus xanthus biofilms as revealed by electron microscopic tomography. J Bacteriol. 2009;191(7):2077–2082. DOI:10.1128/JB.01333-08
   PubMed Web of Science ®Google Scholar
• Kadurugamuwa JL, Beveridge TJ. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacterial. 1995;177(14):3998–4008. Accessed 08 04 2022.
   PubMed Web of Science ®Google Scholar
• Rumbo C, Fernández-Moreira E, Merino M, et al. Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(7):3084–3090. DOI:10.1128/AAC.00929-10
   PubMed Web of Science ®Google Scholar
• Fulsundar S, Harms K, Flaten GE, et al. Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. Appl Environ Microbiol. 2014;80(11):3469–3483. DOI:10.1128/AEM.04248-13
   PubMed Web of Science ®Google Scholar
• McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gram‐negative bacteria is a novel envelope stress response. Mol Microbiol. 2007;63(2):545–558. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd B, Zomer G, van den Ijssel J, et al. Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development. PLoS One. 2013;8(1):e54314. DOI:10.1371/journal.pone.0054314
   PubMed Web of Science ®Google Scholar
• Balhuizen MD, Veldhuizen EJ, Haagsman HP. Outer membrane vesicle induction and isolation for vaccine development. Front Microbiol. 2021;12:79. Accessed 20 07 2022.
   Web of Science ®Google Scholar
• Soltani MS, Eftekhar F, Noofeli M, et al. Comparison of two different methods for the extraction of outer membrane vesicles from the Bordetella pertussis as a vaccine candidate. Arch Razi Inst. 2021;76(3):411. DOI:10.22092/ARI.2020.342861.1487
   PubMedGoogle Scholar
• Lane AG. Appearance of mouse-lethal toxin in liquid cultures of Bordetella pertussis. Appl Microbiol. 1968;16(9):1400–1405. Accessed 08 04 2022.
   PubMedGoogle Scholar
• Morse JH, Morse SI. Studies on the ultrastructure of Bordetella pertussis: i. Morphology, origin, and biological activity of structures present in the extracellular fluid of liquid cultures of Bordetella pertussis. J Exp Med. 1970;131(6):1342. Accessed 20 07 2022.
   PubMed Web of Science ®Google Scholar
• Poolman J, Hamstra HJ, Barlow A, et al. Outer membrane vesicles of Bordetella pertussis are protective antigens in the mouse intracerebral challenge model. Proceedings of the Sixth International Symposium on Pertussis 26-28 September 1990 Bethesda, Maryland, USA. 1990:148–156. Accessed 11 08 2022.
   Google Scholar
• Hozbor D, Rodriguez ME, Fernandez J, et al. Release of outer membrane vesicles from Bordetella pertussis. Curr Microbiol. 1999;38(5):273–278. DOI:10.1007/PL00006801
   PubMed Web of Science ®Google Scholar
• Donato GM, Goldsmith CS, Paddock CD, et al. Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles. FEBS Lett. 2012;586(4):459–465. DOI:10.1016/j.febslet.2012.01.032
   PubMed Web of Science ®Google Scholar
• Gasperini G, Arato V, Pizza M, et al. Physiopathological roles of spontaneously released outer membrane vesicles of Bordetella pertussis. Future Microbiol. 2017;12(14):1247–1259. DOI:10.2217/fmb-2017-0064
   PubMed Web of Science ®Google Scholar
• Fiocca R, Necchi V, Sommi P, et al. Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J Pathol. 1999;188(2):220–226. DOI:10.1002/(SICI)1096-9896(199906)188:2<220:AID-PATH307>3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Kesty NC, Mason KM, Reedy M, et al. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. J Embo. 2004;23(23):4538–4549. DOI:10.1038/sj.emboj.7600471
   PubMed Web of Science ®Google Scholar
• Chatterjee D, Chaudhuri K. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett. 2011;585(9):1357–1362. Accessed 28 06 2022.
   PubMed Web of Science ®Google Scholar
• Roberts R, Moreno G, Bottero D, et al. Outer membrane vesicles as acellular vaccine against pertussis. Vaccine. 2008;26(36):4639–4646. DOI:10.1016/j.vaccine.2008.07.004
   PubMed Web of Science ®Google Scholar
• Gasperini G, Biagini M, Arato V, et al. Outer membrane vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to Bordetella pertussis adhesion to epithelial cells. Mol Cell Proteomics. 2018 2; 17(2): 205–215. 10.1074/mcp.RA117.000045.
   PubMed Web of Science ®Google Scholar
• De Jonge EF, Balhuizen MD, Van Boxtel R, et al. Heat shock enhances outer-membrane vesicle release in Bordetella spp. Crmicr. 2021;2:100009. Accessed 28 06 2022.
   Google Scholar
• Raeven RH, Rockx-Brouwer D, Kanojia G, et al. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses. Sci Rep. 2020;10(1):1–11. DOI:10.1038/s41598-020-63998-2
   PubMed Web of Science ®Google Scholar
• Kanojia G, Raeven RH, van der Maas L, et al. Development of a thermostable spray-dried outer membrane vesicle pertussis vaccine for pulmonary immunization. J Control Release. 2018;286:167–178. Accessed 28 04 2022.
   PubMed Web of Science ®Google Scholar
• Loscher C, Donnely S, McBennett S, et al. Proinflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine. Ann N Y Acad Sci. 1998;856(1 MOLECULAR MEC):274–277. DOI:10.1111/j.1749-6632.1998.tb08337.x
   PubMedGoogle Scholar
• Geurtsen J, Vandebriel RJ, Gremmer ER, et al. Consequences of the expression of lipopolysaccharide-modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines. Microbes Infect. 2007;9(9):1096–1103. DOI:10.1016/j.micinf.2007.04.015
   PubMed Web of Science ®Google Scholar
• Asensio CJ, Gaillard ME, Moreno G, et al. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid a deacylase PagL as a novel acellular vaccine candidate. Vaccine. 2011;29(8):1649–1656. DOI:10.1016/j.vaccine.2010.12.068
   PubMed Web of Science ®Google Scholar
• Gaillard ME, Bottero D, Errea A, et al. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes. Vaccine. 2014;32(8):931–937. DOI:10.1016/j.vaccine.2013.12.048
   PubMed Web of Science ®Google Scholar
• Ormazábal M, Bartel E, Gaillard ME, et al. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles. Vaccine. 2014;32(46):6084–6090. DOI:10.1016/j.vaccine.2014.08.084
   PubMed Web of Science ®Google Scholar
• Raeven RH, van Vlies N, Salverda ML, et al. The role of virulence proteins in protection conferred by Bordetella pertussis outer membrane vesicle vaccines. Vaccines (Basel). 2020;8(3):429. DOI:10.3390/vaccines8030429
   PubMed Web of Science ®Google Scholar
• Zurita ME, Wilk MM, Carriquiriborde F, et al. A pertussis outer membrane vesicle-based vaccine induces lung-resident memory CD4 T cells and protection against Bordetella pertussis, including pertactin deficient strains. Front Cell Infect Microbiol. 2019;9:125. Accessed 11 08 2022.
   PubMed Web of Science ®Google Scholar
• Carriquiriborde F, Martin Aispuro P, Ambrosis N, et al. Pertussis vaccine candidate based on outer membrane vesicles derived from biofilm culture. Front Immunol. 2021;12:3740. DOI:10.3389/fimmu.2021.730434
   Web of Science ®Google Scholar
• Bottero D, Gaillard ME, Zurita ME, et al. Characterization of the immune response induced by pertussis OMVs-based vaccine. Vaccine. 2016;34(28):303–3309. DOI:10.1016/j.vaccine.2016.04.079
   Web of Science ®Google Scholar
• Raeven RH, Brummelman J, Pennings JL, et al. Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep. 2016;6(1):1–15. DOI:10.1038/srep38240
   PubMedGoogle Scholar
• Elizagaray ML, Gomes MTR, Guimaraes ES, et al. Canonical and non-canonical inflammasome activation by outer membrane vesicles derived from Bordetella pertussis. Front Immunol. 2020;11:1879. DOI:10.3389/fimmu.2020.01879
   PubMed Web of Science ®Google Scholar